Immunohistochemical evidence of immunopathogenetic mechanisms in chronic hepatitis C recurrence after liver transplantation

Hepatology

Volumn 26, Issue 3, 1997, Pages 755-763

  Asanza, Cecilia G ^a   García Monzón, Carmelo ^b   Clemente, Gerardo ^a   Salcedo, Magdalena ^a   García Buey, Luisa ^b   García Iglesias, Consuelo ^b   Bañares, Rafael ^a   Alvarez, Emilio ^a   Moreno Otero, Ricardo ^b,c  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BETA 2 MICROGLOBULIN; CYCLOSPORIN; INTERCELLULAR ADHESION MOLECULE 1; METHYLPREDNISOLONE; PREDNISONE; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ANTIGEN RECOGNITION; ARTICLE; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; FEMALE; GRAFT REJECTION; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; LIVER INJURY; LIVER TRANSPLANTATION; LYMPHOCYTE ACTIVATION; MALE; PRIORITY JOURNAL; RECURRENCE RISK;

EID: 0030768454     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510260331     Document Type: Article

References (59)

1. Wright TL, Donegan E, Hsu HH, Ferrell L, Lake JR, Kim M, Combs C, et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992;103:317-322.
2. Féray C, Samuel D, Thiers V, Gigou M, Pichon F, Bismuth A, Reynes M, et al. Reinfection of liver graft by hepatitis C virus after liver transplantation. J Clin Invest 1992;89:1361-1365.
3. Sallie R, Cohen A, Tibbs C, Portmann B, Rayner A, O'Grady J, Tan KC, et al. Recurrence of hepatitis C following orthotopic liver transplantation: a polymerase chain reaction and histological study. J Hepatol 1994; 21:536-542.
4. Féray G, Gigou M, Samuel D, Paradis V, Wilber J, David MF, Urdea M, et al. The course of hepatitis C infection after liver transplantation. HEPATOLOGY 1994;20:1137-1143.
5. Chazouilleres O, Kim M, Combs C, Ferrell L, Bachetti P, Roberts J, Ascher NL, et al. Quantification of hepatitis C virus RNA in liver transplant recipients. Gastroenterology 1994;106:994-999.
6. Freeman RB, Tran S, Lee YM, Rohrer RJ, Kaplan MM. Serum hepatitis C RNA titers after liver transplantation are not correlated with immunosuppression or hepatitis. Transplantation 1996;61:542-546.
7. Martell M, Esteban JL, Quer J, Vargas V, Esteban R, Guardia J, Gomez J. Dynamic behaviour of hepatitis C quasispecies in patients undergoing orthotopic liver transplantation. J Virol 1994;68:3425-3436.
8. Gretch D, Wile M, Gaur L, Lesniewski R, Nelson K, Strong M, Johnson R, et al. Donor recipient match at the HLA-DQB locus is associated with recrudescence or chronic hepatitis following liver transplantation for end-stage hepatitis C [Abstract]. HEPATOLOGY 1993;18:108A.
9. Gane E, Donaldson P, Underhill J, Naoumov N, Portmann B, Williams R. The degree of donor/recipient HLA mismatch does not influence the severity of liver graft damage following hepatitis C recurrence [Abstract]. J Hepatol 1995;23(suppl 1):67A.
10. Salcedo M, Bañares R, Alvarez E, Asanza CG, de Diego A, Valdecantos E, Cos E, et al. Hepatitis C virus reinfection after liver transplantation: outcome and factors associated with severe graft disease [Abstract]. HEPATOLOGY 1995;22(suppl):115A.
11. Bamber M, Murray AK, Weller IVD, Morelli A, Scheuer PJ, Thomas HC, Sherlock S. Clinical and histological features of a group of patients with sporadic non-A,non-B hepatitis. J Clin Pathol 1981;34:1175-1180.
12. Ommata M, Iwama S, Sumida M, Ito Y, Okuda. Clinicopathological study of acute non-A non-B postransfusion hepatitis: histological features in acute phase. Liver 1981;1:201-208.
13. Dienes HP, Popper H, Arnold W, Loebeck H. Histological observations in human hepatitis non-A, non-B. HEPATOLOGY 1982;2:552-571.
14. Lau JYN, Davis GL, Kniffen J, Qian KP, Urdea MS, Chan CS, Mikozami M, et al. Significance of serum hepatitis C virus (HCV) RNA levels in chronic HCV infection. Lancet 1993;341:1501-1504.
15. Hiramatsu N, Hayashi N, Haruna Y, Kasahara A, Fusamoto H, Mori C, Fuke I, et al. Immunohistochemical detection of hepatitis C virus-infected hepatocytes in chronic liver disease with monoclonal antibodies to core, envelope and NS3 regions of the hepatitis C virus genome. HEPATOLOGY 1992;16:306-311.
16. Krawczynski K, Beach MJ, Bradley DW, Kuo G, DiBisceglie AM, Houghton M, Reyes G, et al. Hepatitis C virus antigen in hepatocytes: immunomorphologic detection and identification. Gastroenterology 1992;103:622-629.
17. Vento S, Cruciani M, di Perri G, Garaofano T, Concia E, Ferraro T, Bassetti D. Hepatitis C viraemia with normal liver histology in symptomless HIV-1 infection [Letter]. Lancet 1992;340:1161.
18. Navas S, Castillo I, Bartolomé J, Marriot E, Herrero M, Carreño V. Positive and negative hepatitis C virus RNA strands in serum, liver and peripheral blood mononuclear cells in anti-HCV patients: relation with the liver lesion. J Hepatol 1994;21:182-186.
19. Mondelli M, Alberti A, Tremolada F, Williams R, Eddleston ALWF, Realdi G. In vitro cell mediated cytotoxicity for autologous liver cells in chronic non-A non-B hepatitis. Clin Exp Immunol 1986;63:147-155.
20. García-Monzón C, Moreno-Otero R, Pajares JM, García-Sánchez A, Lopez-Botet M, de Landazurri MO, Sánchez-Madrid F. Expression of a novel activation antigen on intrahepatic CD8+ T lymphocytes in viral chronic hepatitis. Gastroenterology 1990;98:1029-1035.
21. García-Buey L, López-Botet M, García-Sánchez A, Balboa M, Aramburu J, García-Monzón C, Acevedo A, et al. Variability in the expression of a β2-microglobulin epitope on hepatocytes in chronic type C upon treatment with interferon. HEPATOLOGY 1993;17:372-382.
22. Volpes R, Van den Oord JJ, Desmet VJ. Immunohistochemical study of adhesion molecules in liver inflammation. HEPATOLOGY 1990;12:59-65.
23. García-Monzón C, García-Buey L, García-Sánchez A, Pajares JM, Moreno-Otero R. Down regulation of intercellular adhesion molecule-1 on hepatocytes in viral chronic hepatitis treated with interferon alpha-2b. Gastroenterology 1993;105:462-469.
24. García-Monzón C, Sánchez Madrid F, García-Buey L, García-Arroyo A, García-Sánchez A, Moreno Otero R. Vascular adhesion molecule expression in viral chronic hepatitis: evidence of neoangiogenesis in portal tracts. Gastroenterology 1995;108:231-241.
25. Moreno-Otero R, García-Buey L, Mateos FG, García-Monzón C. Pathogenesis of chronic viral hepatitis: lessons from immunohistochemistry. Viral Hepatitis Rev 1996;2:61-79.
26. Young KK, Resnick R, Myers TH. Detection of hepatitis C virus RNA by a combined reverse-transcription-polymerase chain reaction assay. J Clin Microbiol 1993;31:882-886.
27. Spits H, Yssel H, Leeuwenberg J, De Vries JE. Antigen specific cytotoxic T cell and antigen-specif proliferation T cell clones can be induced to cytolytic activity by monoclonal antibodies against T3. J Immunol 1985; 15:88-93.
28. Carrera AC, Sánchez-Madrid F, López-Botet M, Bernabeu C, de Landázuri MO. Involvement of CD4 molecule in a postactivation event on T cell proliferation. Eur J Immunol 1987;17:179-186.
29. Cabañas C, Sánchez-Madrid F, Acevedo A, Bellón T, Fernández JM, Larraga V, Bernabeu C. Characterization of a CD11c reactive monoclonal antibody (HC1/1) obtained by immunizing with phorbol ester differentiated U937 cell. Hybridoma 1987;7:167-176.
30. Campanero MR, del Pozo MA, García-Arroyo A, Sánchez-Mateos P, Hernández-Caselles T, Craig A, Pulido R, et al. ICAM-3 interacts with LFA-1 and regulates the LFA-1/ICAM-1 cell adhesion pathway. J Cell Biol 1993;123:1007-1016.
31. Rothlein R, Dustin ML, Marlin SD, Springer TA. A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J Immunol 1986; 137:1270-1274.
32. Leach L, Clark P, Lampugnani MG, García-Arroyo A, Dejana E, Firth JA. Immunoelectron characterization of the inter-endothelial junctions of human term placenta. J Cell Sci 1993;104:1073-1081.
33. Schhwartz BR, Wayner EA, Carlos TM, Ochs HD, Harlan JM. Identification of surface proteins mediating adherence of CD11/CD18 deficient lymphoblastoid cells to cultured human endothelium. J Clin Invest 1990;85:2109-2022.
34. Cebrián M, Yague E, Rincón M, López-Botet M, de Landazuri MO, Sánchez-Madrid F. Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes. J Exp Med 1988;168:1621-1637.
35. Krensky AM, Sánchez-Madrid F, Robbins E, Nagy JA, Springer TA, Burakoff SJ. The functional significance, distribution and structure of LFA-1, LFA-2, LFA-3: cell surface antigens associated with CTL-target cell interactions. J Immunol 1983;131:611-616.
36. International group. Acute and chronic hepatitis revised. Lancet 1977; 2:914-919.
37. Knodell RG, Ishak KG, Black WC, Ghent S, Craig R, Kaplowitz N, Fierman TN, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. HEPATOLOGY 1981;1:431-435.
38. Scheuer P, Ashrafzadeh P, Sherlock S, Brown D, Dusheiko G. The pathology of hepatitis C. HEPATOLOGY 1992;15:567-571.
39. Navas S, Carreño V. Semiquantification by Amplicor TM assay of hepatitis C virus genome during therapy. J Hepatol 1995;22(suppl 1):115-117.
40. McGuinness PH, Bishop GA, Painter DM, Chan R, McCaughan GW. Intrahepatic hepatitis C RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis C. HEPATOLOGY 1996;23:676-687.
41. Féray C, Gijou M, Samuel D, Parais U, Mishiro S, Maertens G, Reynes M, et al. Influence of the genotypes hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology 1995;108:1089-1096.
42. Jane E, Naoumov N, Quian K, Mondelli MU, Maertens G, Portmann BC, Lay JYN, et al. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 1996;110:167-177.
43. Volpes R, Van den Odord J, Desmet V. Memory T cells represent the predominent lymphocyte subset in acute and chronic liver inflammation. HEPATOLOGY 1991;13:826-829.
44. Hata K, van Thiel DH, Herberman RB, Whiteside TH. Phenotypic and functional characteristics of lymphocytes isolated from liver biopsy specimens from patients with active liver disease. HEPATOLOGY 1992; 15:816-823.
45. Koziel MJ, Dudley D, Wong JT, Dienstag J, Houghton M, Rainston R, Walker BD. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol 1992;149:3339-3344.
46. Ballardini G, Bianchi FB, Marakian R, Fallani M, Pisi E, Bottazzo GF. HLA-A,B,C, HLA-D/DQ expression on unfixed liver biopsy sections from patients with chronic liver disease. Clin Exp Immunol 1987;70: 35-46.
47. Lobo-Yeo A, Senaldi G, Portmann B, Mowat AP, Mieli-Vergani G, Vergani D. Class I and class II major histocompatibility complex antigen expression on hepatocytes: a study in children with liver disease. HEPATOLOGY 1990;12:224-232.
48. Patarroyo M, Makgoba MW. Leucocyte adhesion to cells in immune and inflammatory responses. Lancet 1989;2:1139-1142.
49. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994;76:301-314.
50. Santis AG, Campanero MR, Alonso JL, Tugores A, Alonso MA, Yague E, Pivel JP, et al. Tumor necrosis factor-alfa production induced in T lymphocytes through the AIM/CD69 activation pathway. Eur J Immunol 1992;22:1253-1259.
51. González-Amaro R, García-Monzón C, García-Buey L, Moreno-Otero R, Alonso JL, Yague E, Pivel JP, et al. Induction of tumor necrosis factor alpha production by human hepatocytes in chronic viral hepatitis. J Exp Med 1994;179:841-848.
52. Hemler ME, Elices MJ, Parker C, Takuda Y. Structure of the integrin VLA-4 and its cell-cell and cell-matrix adhesion functions. Immunol Rev 1990;114:45-65.
53. Postigo AA, Teixido J, Sánchez-Madrid F. The alfa4 beta1/VCAM-1 adhesion pathway in physiology and disease. Res Immunol 1994;144: 723-735.
54. Muller WA, Berman ME, Newman PJ, DeLisser HM, Albelda SM. A heterophilic adhesion mechanism for platelet/endothelial cell adhesion molecule 1 (CD31). J Exp Med 1992;175:1401-1404.
55. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991;251:1451-1455.
56. Muller WA, Weigl SA, Den X, Phillips DM. PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med 1993;178: 449-460.
57. Cheifetz S, Bellón T, Calés C, Vera S, Bernabeu C, Massagué J, Letarte M. Endoglin is a component of the transforming growth factor-Beta receptor system in human endothelial cells. J Biol Chem 1992;267: 19027-19030.
58. Bellón T, Corbi A, Lastres P, Calés C, Cebrián M, Vera S, Cheifetz S, et al. Identification of an expression of two forms of the human transforming growth factor-Beta-binding protein endoglin with distinct cytoplasmic regions. Eur J Immunol 1993;23:2340-2345.
59. Moses HL, Yang EY, Pietenpol JA. TGF-β stimulation and inhibition of cell proliferation. New mechanistic insights. Cell 1990;63:245-247.